Goldenwell Biotech (Goldenwell Biotech) Additional Paid-In Capital : $1.30 Mil(As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Goldenwell Biotech Additional Paid-In Capital?

Goldenwell Biotech's quarterly additional paid-in capital stayed the same from Sep. 2023 ($1.30 Mil) to Dec. 2023 ($1.30 Mil) and stayed the same from Dec. 2023 ($1.30 Mil) to Mar. 2024 ($1.30 Mil).

Goldenwell Biotech's annual additional paid-in capital increased from Dec. 2021 ($0.42 Mil) to Dec. 2022 ($1.30 Mil) but then stayed the same from Dec. 2022 ($1.30 Mil) to Dec. 2023 ($1.30 Mil).

Goldenwell Biotech Additional Paid-In Capital Historical Data

The historical data trend for Goldenwell Biotech's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Goldenwell Biotech Additional Paid-In Capital Chart

Goldenwell Biotech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

0.33

0.42

1.30

Goldenwell Biotech Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial										1.30	1.30	1.30	1.30	1.30

Goldenwell Biotech Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Goldenwell Biotech Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Goldenwell Biotech's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Goldenwell Biotech (Goldenwell Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Goldenwell Biotech Inc (OTCPK:GWLL) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

2071 Midway Drive, Twinsburg, OH, USA, 44087

Website

https://www.goldenwellbiotech.com

Goldenwell Biotech Inc is engaged in the research and development, production and sales of health care and supplements products. Its products comprise JI MAI - Bovine Cardiac Vascular Active Peptide, Double Proline AG - 3D Active Collagen Peptide, Cartilage Peptide - Type II collagen peptide, and Sugar Master.

Executives

Li Yang	director, 10 percent owner, officer: Treasurer	C/O GOLDENWELL BIOTECH, INC., 2071 MIDWAY DRIVE, TWINSBURG OH 44087
Hua Xie	director, officer: Secretary	C/O GOLDENWELL BIOTECH, INC., 2071 MIDWAY DRIVE, TWINSBURG OH 44087
Shuang Liu	director, 10 percent owner, officer: Chief Executive Officer	C/O GOLDENWELL BIOTECH, INC., 2071 MIDWAY DRIVE, TWINSBURG OH 44087

Goldenwell Biotech (Goldenwell Biotech) Headlines

No Headlines